arrow
D

Diego A. Pereira-Martins

University of Groningen
H指数:16
被引数:868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High METTL16 expression is associated with inferior overall survival and transcriptional features of primitive cellular states in acute myeloid leukaemia

高 <i>METTL16</i> 表达与急性髓系白血病中较差的总生存期和原始细胞状态的转录特征相关

2026-10-220
PRE
SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models

SLIT2调节急性髓系白血病模型中白血病细胞的增殖和基质支持

2026-09-290
PRE
A genetic risk score based on BCL11A and HBS1L-MYB variants predicts clinical severity in Brazilian sickle cell anaemia patients

基于BCL11A和HBS1L-MYB变异的遗传风险评分可预测巴西镰状细胞贫血患者的临床严重程度

2026-04-160
OAAI
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape

Quizartinib诱导的耐药性驱动具有分子改变以实现多药抗白血病逃逸的MV4-11细胞的克隆出现

2026-04-150
OAAI
Vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D levels: association with cerebrovascular disease in sickle cell anemia

维生素D受体基因多态性与25-羟基维生素D水平:与镰状细胞贫血脑血管疾病的关联

2025-12-010
PRE
Metformin induces ferroptosis associated with lipidomic remodeling in AML

二甲双胍诱导与脂质组重塑相关的铁死亡在AML中

2025-11-040
OAAI
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability

高mtDNA含量可识别氧化磷酸化驱动的急性髓性白血病,并代表治疗脆弱性

2025-07-140
OAAI
Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations
2025-03-010
OAAI
DGATI Inhibition Enhances Metformin-Induced Ferroptosis in AML By Targeting Lipid Metabolism

DGATI 抑制通过靶向脂质代谢增强二甲双胍诱导的AML中铁死亡

BLOOD
IF23.1
2024-11-051
PRE
The Oncogenic ΔNp73α Isoform Contributes to Aggressiveness in APL By Leading to ATRA Resistance through NANOG/BMP4 Axis Upregulation

癌基因ΔNp73α异构体通过上调NANOG/BMP4轴导致ATRA耐药性,从而促进APL的侵袭性。

BLOOD
IF23.1
2024-11-050
PRE
The Oncogenic Function of the Intrinsically Disordered Transcriptional Regulator MN1 Depends on the Chaperone DNAJB6b

内源无序转录调控因子MN1的致癌功能依赖于分子伴侣DNAJB6b

BLOOD
IF23.1
2024-11-050
PRE